HEPSA

Impacts of COVID-19 on BBVSTI testing, care and treatment: Medicare data analysis

By: WHO Collaborating Centre for Viral Hepatitis | Peter Doherty Institute for Infection and ImmunityMelbourne Peter Doherty Institute for Infection and Immunity 2021Description: 17pSubject(s): General reference: Statistics | General reference: Other communicable diseasesOnline resources: Click here to access online Summary: During the period affected by COVID-19 there were substantial declines in hep screening, STI screening and hep B monitoring, and an acceleration in the decline in hep C monitoring. Related term: Coronavirus
Tags from this library: No tags from this library for this title.
Holdings
Item type Current library Call number Status Date due Barcode
Book/report Library
Online
Available

English

During the period affected by COVID-19 there were substantial declines in hep screening, STI screening and hep B monitoring, and an acceleration in the decline in hep C monitoring.

Related term: Coronavirus

Click on an image to view it in the image viewer